穴位注射喘可治注射液对支气管哮喘患儿细胞免疫的影响  

Effect of Acupoint Injection with Chuankezhi on Cellular Immunity in Children with Bronchial Asthma

作　　者：罗娟娟[1] 洪虹[1] 钟小明[1] 谢忠丽 罗开源[1] 

机构地区：[1]赣南医学院第一附属医院,江西赣州341000

出　　处：《赣南医学院学报》2017年第6期920-922,924,共4页JOURNAL OF GANNAN MEDICAL UNIVERSITY

基　　金：2014年江西省卫生计划生育委员会中医药课题(编号:2014A125)

摘　　要：目的:研究穴位注射喘可治注射液对支气管哮喘患儿细胞免疫的影响。方法:选取78例支气管哮喘患儿为研究对象,随机分为治疗组(39例)与对照组(39例)。两组均给予西医常规治疗,治疗组加用穴位注射喘可治注射液,两组疗程均为6天。两组之间和两组治疗前后进行病情评估,并均采血测定细胞免疫,即T细胞亚群(CD_4,CD_8,CD_4/CD_8)。结果:治疗组总有效率为92.3%,明显优于对照组的61.5%(P<0.01);治疗组治疗后CD_4和CD_4/CD_8比值上升,与治疗前比较,P<0.01;2组治疗后比较有统计学差异(P<0.05)。结论:穴位注射喘可治注射液能够改善支气管哮喘患儿的细胞免疫功能,该方法可以作为支气管哮喘的重要辅助治疗。Objective： To study the effect of acupoint injection with Chuankezhi on the cellular immunity in children with bronchial asthma.Methods： Seventy-eight cases of bronchial asthma in children for the study were randomly divided into treatment group（39 cases） and control group（39 cases）.Both groups were given routine western medicine,and the treatment group was treated with Chuankezhi acupoint injection.Both were treated for six days.Condition assessment was carried out between the two groups,and before and after treatment.and were measured blood cell-mediated immunity,T cell subsets（CD4,CD8,CD4/CD8）.The cell immunity,namely,T cell subsets（CD4,CD8,CD4/CD8） was measured by blood sampling.Results： The total effective rate of the treatment group was 92.3%,obviously superior to that of the control group（61.5%）（P 〈 0.01）; The ratio of CD4 and CD4/CD8 of the treatment group increased after treatment compared with before treatment（P 〈 0.01）.There was a statistical difference between the two groups after treatment（P〈 0.05）.Conclusion： Acupoint injection with Chuankezhi injection can improve the cellular immune function of children with asthma.It can be used as an important adjuvant therapy for bronchial asthma.

关 键 词：穴位注射 喘可治 支气管哮喘 细胞免疫(T细胞亚群) 

分 类 号：R725.9[医药卫生—儿科]